“Science is showing us the path to a future in which new therapeutic options may provide both solutions as well… Read more »
Tag: Aimmune
Europe’s Palforizia OIT Study Shows Speed of Desensitization
Phase 3 results from the European clinical trial of the Palforzia peanut OIT treatment show that desensitization to the allergenic… Read more »
Learning More About Oral Immunotherapy for Food Allergy
Allergist Dr. Michael Manning explains how oral immunotherapy (OIT) for food allergy works and shares his experience working with families to ease anxiety.
Palforzia OIT Study Sees Maturing of Immune System Over Time
A new study finds encouraging results for those considering the first FDA-approved peanut allergy immunotherapy. It reveals that clinical trial… Read more »
Allergists See Palforzia Starting New Era of Food Allergy Therapy
Allergists that Allergic Living contacted are excited about the FDA’s approval of the first-ever therapy for a food allergy. They… Read more »
FDA Approves Aimmune’s Palforzia OIT, Coming Soon to Allergist Clinics
The Food and Drug Administration on Jan. 31, 2020 approved Palforzia, Aimmune Therapeutics’ oral immunotherapy (OIT) treatment for peanut allergy… Read more »
Editor’s Remarks to FDA Committee on Peanut Allergy Drug
Allergic Living’s Gwen Smith presented the following statement on Sept. 13, 2019 to the FDA’s Allergenic Products Advisory Committee, which was… Read more »
Panel Backs FDA Approval for Aimmune’s Peanut OIT Drug
An expert advisory panel has recommended that the Food and Drug Administration approve Aimmune Therapeutics’ oral immunotherapy (OIT) treatment for… Read more »
Concerns Raised as ICER Report Praises Peanut Avoidance vs. Therapy
In its final report analyzing the costs and benefits of two novel peanut allergy desensitization products, the Institute for Clinical… Read more »
Peanut Allergy Therapies: ICER’s Review Draws Criticism
What do you get when you undertake a cost-benefit analysis of new therapies when prices have yet to be established… Read more »